Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Twice- or Once-Daily Dosing of Novel Oral Anticoagulants for Stroke Prevention: A Fixed-Effects Meta-Analysis with Predefined Heterogeneity Quality Criteria

Table 3

Reported safety outcomes (HRs [95% CI] vs warfarin) of the respective NOACs in the phase 3 trials [1]–[5] in the safety analysis sets.

Table 3

doi: https://doi.org/10.1371/journal.pone.0099276.t003